Answers are grounded in this paper and cite their sources.
The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) occurring downstream in the PI3K/Akt/mTOR pathway, are regarded as potential prognostic markers for gastric cancer (GC). However, the prognostic value of mTOR/p-mTOR expression remains controversial. In this study, we determined the expression of mTOR, p-mTOR, p70S6k, and p-p70S6K in GC, and investigated the correlation between their overexpression, clinicopathological parameters, and overall survival (OS).
No takes yet. Share an insight, caveat, or question.
Cao et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: